Population
Patients with myocarditis, dilated cardiomyopathy, and hypertrophic cardiomyopathy
Design
Review
Authors
Loading...
Should not alter myocarditis management; leaves open whether targeting viral or nitric oxide pathways improves cardiomyopathy outcomes.
Highlights the emerging understanding of immune mechanisms, specifically cytokines and nitric oxide, in the progression from viral myocarditis to cardiomyopathy.
Akira Matsumori (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: